5 Biggest European Pharmaceutical Companies

3. AstraZeneca PLC (NASDAQ:AZN)

Market Capitalization as of November 22, 2022: $201 billion

AstraZeneca PLC (NASDAQ:AZN) is a British firm that develops pharmaceutical products. These include drugs for influenza, bipolar disorder, schizophrenia, obesity, and other diseases. The firm is based in Cambridge, the United Kingdom.

AstraZeneca PLC (NASDAQ:AZN) raked in a whopping $10.7 billion in revenue during its second fiscal quarter, which marked a strong 31% annual growth. Out of this, $3.7 billion was contributed by the firm’s cancer drug portfolio. As if this weren’t enough, AstraZeneca PLC (NASDAQ:AZN)’s third quarter saw it bring in another $11 billion in revenue, which led to the total revenue for the first three quarters sitting at a massive $33 billion, representing 37% annual growth.

Insider Monkey studied 920 hedge fund portfolios for Q3 2022 to discover that 44 funds had bought AstraZeneca PLC (NASDAQ:AZN)’s shares. Out of these funds, Rajiv Jain’s GQG Partners is AstraZeneca PLC (NASDAQ:AZN)’s largest shareholder. It owns 18 million shares that are worth $1 billion.

Follow Astrazeneca Plc (NYSE:AZN)